Observational studyBreast (Edinburgh, Scotland)2021

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.

Debora Basile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.